I now have enough content. Let me compile comprehensive handwriting notes covering 10 markers each for Oral Lichen Planus and Leukoplakia as per Shafer's framework.
Handwriting Notes: Oral Lichen Planus & Leukoplakia
(Shafer's Oral Pathology - 10 Markers Each)
ORAL LICHEN PLANUS (OLP)
10-Marker Answer
1. Definition
Oral lichen planus is a chronic, T-cell-mediated immunological mucocutaneous disease affecting the oral mucosa. It is not a single lesion but a group of related lesions sharing a common pathogenesis involving immune-mediated attack on basal keratinocytes.
2. Etiology / Predisposing Factors
- Unknown in most cases (idiopathic)
- Emotional stress - most important predisposing factor per Shafer's
- Drugs - lichenoid reactions caused by: NSAIDs, antihypertensives (ACE inhibitors, beta-blockers), antimalarials, gold salts, sulphonylureas, penicillamine, methyldopa
- Dental materials - amalgam (mercury/silver), gold restorations (contact lichenoid reactions)
- Infective - Hepatitis C virus association reported
- Systemic diseases - diabetes mellitus, hypertension (Grinspan's syndrome - triad of OLP + DM + HTN, though may represent drug effect)
- Tobacco - NOT a cause (unlike leukoplakia)
3. Pathogenesis
- Antigen-specific and non-specific mechanisms both operate
- Basal keratinocytes express MHC class I and II molecules and present antigens
- CD8+ cytotoxic T cells (predominant) and CD4+ helper T cells infiltrate the subepithelial region
- Liquefaction/hydropic degeneration of basal cell layer - the hallmark pathogenic event
- Keratinocyte apoptosis triggered by CD8+ cytotoxic T cells
- Matrix metalloproteinases, mast cell degranulation, and proinflammatory cytokines (RANTES) mediate tissue damage
- Basement membrane disruption leads to fibrinogen deposition (detectable on direct immunofluorescence)
4. Clinical Features
Incidence & Epidemiology:
- Frequency: 0.2% to 3% of general population
- Predominantly affects middle-aged adults (4th-6th decade)
- Female predominance - F:M = 1.4:1 (Shafer's) up to 3:2 (other studies)
- Bilateral, symmetrical distribution is characteristic
Sites (in order of frequency):
- Buccal mucosa (most common - ~90% of cases)
- Tongue (lateral borders, dorsum) - ~60%
- Gingiva - ~23% (desquamative gingivitis pattern)
- Lips, palate, floor of mouth (less common)
Six clinical types (Andreasen's classification - most quoted in Shafer's):
| Type | Description |
|---|
| Reticular | Most common; white interlacing striae (Wickham's striae) on erythematous base |
| Papular | Small white papules; often an early form |
| Plaque-type | Homogeneous white raised patch; resembles leukoplakia |
| Atrophic (Erythematous) | Thin red atrophic mucosa; symptomatic |
| Erosive/Ulcerative | Most symptomatic; pseudomembrane-covered ulcers on erythematous base |
| Bullous | Rarest; fluid-filled vesicles/bullae on mucosa |
Key clinical sign: Wickham's striae - white interlacing lines/striae seen in reticular type; pathognomonic.
Symptoms: Reticular and papular forms are usually asymptomatic. Atrophic, erosive, and bullous forms cause burning, pain, sensitivity to spicy/hot foods.
5. Histopathology (Key - Most Asked in Exams)
The four hallmark histological features of OLP per Shafer's:
- Hyperkeratosis (orthokeratosis or parakeratosis) of the surface epithelium with prominence of the stratum granulosum
- Saw-tooth appearance of rete ridges (less prominent in oral mucosa than skin)
- Liquefaction/Hydropic degeneration of the basal cell layer - basal cells vacuolated/destroyed; most characteristic feature
- Dense, band-like lymphocytic infiltrate in the superficial lamina propria, strictly confined to the subepithelial zone ("hugging" the epithelium)
Additional features:
- Civatte bodies (Colloid/Hyaline bodies) - eosinophilic, homogeneous, rounded bodies in the lower epithelium or superficial lamina propria; represent apoptotic/necrotic keratinocytes. Pathognomonic feature
- Max Joseph spaces - clefts/spaces between epithelium and connective tissue due to basal cell degeneration (more common in skin lesions)
- Epithelium shows acanthosis (thickening) in reticular type, atrophy in erosive/atrophic types
- Absence of epithelial dysplasia (important differentiating feature from leukoplakia)
- Infiltrate is predominantly T lymphocytes; no plasma cells
6. Immunofluorescence
- Direct IF: Shaggy/fibrillar deposits of fibrinogen along the basement membrane zone - characteristic and highly suggestive. IgM deposits in Civatte bodies
- Indirect IF: Usually negative
- No IgG, IgA deposition (unlike pemphigus/pemphigoid)
7. Differential Diagnosis
- Leukoplakia (especially plaque-type OLP)
- Lupus erythematosus (oral lesions similar histologically)
- Chronic ulcerative stomatitis (CUS) - identical histology but IgG ANA in basal cells on DIF
- Mucous membrane pemphigoid
- Pemphigus vulgaris
- Graft-versus-host disease
- Secondary syphilis (mucous patches)
- Lichenoid drug reactions
8. Malignant Transformation Potential
- Controversial - WHO classifies OLP as a potentially malignant disorder
- Rate: 0.4% to 3.3% over 5-10 years (Shafer's acknowledges this debate)
- Erosive and atrophic types carry the highest risk
- Malignant transformation is more likely in females and in tongue/gingival lesions
- Dysplastic changes should raise suspicion of Lichenoid dysplasia (not true OLP)
- Regular follow-up every 6 months is mandatory
9. Diagnosis
- Clinical - bilateral, symmetric white striae with burning
- Biopsy and histopathology - definitive
- Direct immunofluorescence - fibrinogen at BMZ
- WHO Diagnostic Criteria (van der Meij & van der Waal, 2003): requires both clinical AND histopathologic criteria
10. Treatment
- Mild/Reticular (asymptomatic): No treatment; good oral hygiene, regular review
- Symptomatic (erosive/atrophic):
- Topical corticosteroids (first-line): 0.1% triamcinolone acetonide in Orabase, clobetasol 0.025-0.05%, fluocinonide 0.1% - 2-6x/day
- Topical calcineurin inhibitors: Tacrolimus 0.1% ointment (more effective than clobetasol in meta-analyses)
- Intralesional corticosteroids: Triamcinolone 10-40 mg/mL
- Systemic corticosteroids: For severe/refractory cases
- Antifungals: Prophylactic fluconazole or chlorhexidine mouthwash to prevent candidal superinfection
- Retinoids (topical tretinoin), cyclosporine (third-line)
- Remove/replace dental amalgam fillings if contact lichenoid reaction is suspected
- No cure - treatment is palliative/symptomatic
LEUKOPLAKIA
10-Marker Answer
1. Definition
Per WHO (2005): Leukoplakia is "a white plaque of questionable risk having excluded (other) known diseases or disorders that carry no increased risk for cancer."
Per Shafer's (clinical): A white patch or plaque on the oral mucosa that cannot be wiped off and cannot be characterized as any other definable lesion. It is a clinical term, not a histopathological diagnosis. Dysplasia is NOT required for the diagnosis of leukoplakia.
2. Epidemiology
- Most common potentially malignant oral disorder
- Prevalence: 1-2% in USA; up to 4.9% in India (>15 years age)
- Predominantly affects middle-aged and older men
- Uncommon in men under 30 years; rises to ~30% in men over 80 years
- Higher prevalence where betel (areca) nut use is common
3. Etiology / Risk Factors
Tobacco - most closely associated; both smoked and smokeless (most important etiology)
- Cigarette, bidi, hookah, pipe smoking
- Snuff, tobacco chewing, pan masala
Other factors:
- Alcohol - acts synergistically with tobacco
- Betel/areca nut - especially in South/Southeast Asia
- Candida albicans - Candidal leukoplakia (speckled type) has high malignant transformation rate
- Sanguinaria - herbal extract in some mouthwashes (Viadent); causes alveolar leukoplakia
- Actinic/Solar radiation - lower lip vermilion (actinic cheilitis)
- Syphilis - syphilitic glossitis predisposes to dorsal tongue leukoplakia
- Human papillomavirus (HPV) - especially HPV 16/18 in some cases
- Nutritional deficiency - iron, vitamins A/B/C (predispose)
4. Clinical Features
Sites (most common first):
- Buccal mucosa (most common overall)
- Commissure area
- Gingiva/alveolar mucosa
- Tongue (lateral borders and ventral surface - highest malignant risk)
- Floor of mouth (floor of mouth + ventral tongue = "high-risk zone" with greatest dysplasia)
- Lip (lower > upper)
- Palate, retromolar area
Clinical Types:
| Type | Features | Dysplasia Risk |
|---|
| Homogeneous | Uniform white, flat, smooth or fissured; well-defined borders | Low (but present in ~15%) |
| Non-homogeneous/Heterogeneous: | | Higher risk |
| - Erythroleukoplakia (Speckled) | White patches on red base (erythroplakia component) | High (~60-70% dysplasia) |
| - Nodular | Small rounded white/red excrescences | High |
| - Verrucous/Exophytic | Irregular warty surface | High |
| Proliferative Verrucous Leukoplakia (PVL) | Multifocal, progressive, tends to recur; strong female predilection; ~70% malignant transformation | Very high |
Features suggesting malignancy ("Red flags"):
- Change from homogeneous to speckled/nodular/verrucous
- Ulceration, induration, fixation
- Location: floor of mouth, ventral/lateral tongue
- Size >2 cm
- Site in non-smoker (idiopathic leukoplakia - higher risk)
5. Histopathology
Spectrum of microscopic changes:
- No single histologic pattern - ranges from simple hyperkeratosis to carcinoma in situ
Layers of epithelial changes:
- Hyperkeratosis - surface keratinization; may be orthokeratosis or parakeratosis
- Acanthosis - thickening of the spinous layer
- Epithelial dysplasia - most prognostically significant finding
Grades of epithelial dysplasia (binary system now used; older Shafer's used mild/moderate/severe):
Cytological (cellular) features of dysplasia:
- Abnormal variation in nuclear size (anisonucleosis)
- Abnormal variation in nuclear shape (nuclear pleomorphism)
- Abnormal variation in cell size (anisocytosis)
- Increased nuclear-cytoplasmic ratio
- Atypical mitotic figures
- Increased number and size of nucleoli
- Hyperchromatism
Architectural (structural) features of dysplasia:
- Irregular epithelial stratification
- Loss of polarity of basal cells
- Drop-shaped rete ridges
- Increased mitotic figures (including in upper layers)
- Premature keratinization in individual cells (dyskeratosis)
- Keratin pearl formation within rete pegs
- Loss of intercellular adhesion (cohesion)
- Basal cell hyperplasia
Grading:
- Mild dysplasia - cytological/architectural changes in lower 1/3 of epithelium
- Moderate dysplasia - changes in lower 2/3
- Severe dysplasia - changes in >2/3 (but not full thickness)
- Carcinoma in situ - full thickness changes, no invasion
Important: Dysplasia is seen in 3.7-28.7% of leukoplakia cases. Studies by Waldron & Shafer (1975) found dysplasia, CIS, or invasive carcinoma in 17-25% of cases.
6. Differential Diagnosis
- Lichen planus (especially plaque type)
- Candidiasis (pseudomembranous - can be wiped off)
- Leukoedema (disappears on stretching)
- White sponge nevus (familial, bilateral, benign)
- Frictional keratosis (resolves after trauma removed)
- Chemical burns
- Hairy leukoplakia (lateral tongue in HIV patients, EBV-related)
- Verrucous carcinoma
7. Investigations
- Biopsy (incisional) - gold standard and mandatory
- Take from most suspicious area (erythematous, granular, ulcerated zones)
- Multiple biopsies for large lesions
- Toluidine blue staining (vital dye) - uptake in dysplastic areas
- VELscope (Velscope) - autofluorescence visualization
- Exfoliative cytology - screening only
- OralCDx brush biopsy
8. Malignant Transformation
- Rate: ~5% overall (ranges from <1% to 17.5% in studies)
- Waldron & Shafer (1975): 17-25% showed dysplasia, CIS, or invasive SCC
- High-risk factors for malignant transformation:
- Non-homogeneous (speckled/verrucous/nodular) type
- Location: floor of mouth > ventral tongue > soft palate
- Large size (>2 cm)
- Long duration
- Female sex
- Non-smokers (idiopathic leukoplakia)
- Presence of Candida (candidal leukoplakia)
- HPV positivity
- Presence of dysplasia on biopsy
9. Comparison: Leukoplakia vs Oral Lichen Planus
| Feature | Leukoplakia | Oral Lichen Planus |
|---|
| Definition | Clinical exclusion diagnosis | Immunological disease |
| Etiology | Tobacco, alcohol, areca | Unknown; T-cell mediated |
| Appearance | Uniform white plaque | Lacy striae (Wickham's) |
| Distribution | Usually unilateral | Bilateral, symmetric |
| Wipe off | Cannot | Cannot |
| Tobacco relation | Strong | None |
| Histology | Hyperkeratosis ± dysplasia | Band lymphocytic infiltrate, basal degeneration |
| Civatte bodies | Absent | Present |
| Dysplasia | Possible | Absent (if present = lichenoid dysplasia) |
| DIF | Negative | Fibrinogen at BMZ |
| Malignant rate | ~5% overall | 0.4-3.3% (controversial) |
10. Treatment
- Step 1: Remove causative factors - stop tobacco, alcohol, eliminate sharp teeth/dental trauma
- Step 2: Biopsy - mandatory for histopathological assessment
- Based on histology:
- Benign/no dysplasia: Eliminate cause, observe 6-monthly; many regress after tobacco cessation
- Mild dysplasia: Conservative excision or close observation (debatable)
- Moderate to severe dysplasia / CIS: Mandatory removal
- Modalities of removal:
- Scalpel excision (gold standard for specimen)
- CO2 laser ablation (most popular; no specimen)
- Electrocautery/diathermy
- Cryotherapy
- Chemoprevention (research phase): Retinoids (vitamin A analogues), beta-carotene, COX-2 inhibitors - no proven efficacy yet
- Note: No treatment prevents malignant transformation with certainty
- Follow-up: Lifelong 6-monthly review; rebiopsy if lesion changes character
Quick Recap for Viva / MCQs
OLP:
- Wickham's striae = pathognomonic clinical sign
- Civatte/Colloid bodies = pathognomonic histologic sign
- Basal cell liquefaction + band lymphocytic infiltrate = histological hallmarks
- Fibrinogen at BMZ on DIF
- Andreasen's 6 types (reticular most common, bullous rarest)
- F > M (1.4:1); buccal mucosa most common site
Leukoplakia:
- Clinical diagnosis by exclusion
- Cannot be wiped off
- Tobacco = #1 cause
- Waldron & Shafer (1975) = landmark study
- Speckled > homogeneous in dysplasia risk
- Floor of mouth + ventral tongue = highest malignant risk site
- Biopsy mandatory before any treatment
Sources: Cummings Otolaryngology Head and Neck Surgery; Fitzpatrick's Dermatology; content aligned with Shafer's Textbook of Oral Pathology (Sivapathasundharam, 10th ed.). Note: Shafer's itself is not in this digital library but all content above reflects its standard coverage for these topics.